Anaptysbio ANAB
NASDAQ ANAB
$47.94 +2.51 (+5.52%)
At close: Oct 21, 2026 · 4:00 PM EDT

Anaptysbio (ANAB) EV to CFO (2021 - 2026)

Updated

Anaptysbio's EV to CFO was 175.71 in Q1 2026, up 482.7% from the prior quarter.

Analysis

Anaptysbio (ANAB) EV to CFO (2021 - 2026) Analysis & Trends

On a trailing twelve-month basis, Anaptysbio's EV to CFO was -8.82 through Mar 31, 2026; for FY2025, it was 30.15.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Anaptysbio 1.37 Bn 260.54 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 175.71
Dec 31, 2025 30.15
Sep 30, 2021 7.21
Jun 30, 2021 12.01
API Access

Anaptysbio EV to CFO API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-cfo&ticker=ANAB&period=max&api_key=YOUR_API_KEY